Albemarle Optimizes Smallpox Drug Candidate For SIGA
May 15th 2008Drug InformationBio-terrorism
Two American companies are teaming up for second-round test-phase production of a FDA-designated “fast track” drug candidate to treat smallpox, a deadly virus that is feared to be able to reach people through acts of bio-warfare or bio-terrorism.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
